These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1339 related items for PubMed ID: 27039128

  • 1. Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.
    King JB, Shah RU, Bress AP, Nelson RE, Bellows BK.
    JACC Heart Fail; 2016 May; 4(5):392-402. PubMed ID: 27039128
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.
    Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, Rouleau JL, Zile MR, McMurray JJ, Solomon SD.
    JAMA Cardiol; 2016 Sep 01; 1(6):666-72. PubMed ID: 27438344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective.
    Chin KL, Zomer E, Wang BH, Liew D.
    Heart Lung Circ; 2020 Sep 01; 29(9):1310-1317. PubMed ID: 32303468
    [Abstract] [Full Text] [Related]

  • 5. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD, Claggett B, Desai AS, Packer M, Zile M, Swedberg K, Rouleau JL, Shi VC, Starling RC, Kozan Ö, Dukat A, Lefkowitz MP, McMurray JJ.
    Circ Heart Fail; 2016 Mar 01; 9(3):e002744. PubMed ID: 26915374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines.
    Ramos IC, Versteegh MM, de Boer RA, Koenders JMA, Linssen GCM, Meeder JG, Rutten-van Mölken MPMH.
    Value Health; 2017 Dec 01; 20(10):1260-1269. PubMed ID: 29241885
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction.
    Sandhu AT, Ollendorf DA, Chapman RH, Pearson SD, Heidenreich PA.
    Ann Intern Med; 2016 Nov 15; 165(10):681-689. PubMed ID: 27571284
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
    Liang L, Bin-Chia Wu D, Aziz MIA, Wong R, Sim D, Leong KTG, Wei YQ, Tan D, Ng K.
    J Med Econ; 2018 Feb 15; 21(2):174-181. PubMed ID: 28959905
    [Abstract] [Full Text] [Related]

  • 11. Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States.
    Zueger PM, Kumar VM, Harrington RL, Rigoni GC, Atwood A, DiDomenico RJ, Touchette DR.
    Pharmacotherapy; 2018 May 15; 38(5):520-530. PubMed ID: 29601093
    [Abstract] [Full Text] [Related]

  • 12. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand.
    Krittayaphong R, Permsuwan U.
    Am J Cardiovasc Drugs; 2018 Oct 15; 18(5):405-413. PubMed ID: 29926351
    [Abstract] [Full Text] [Related]

  • 13. Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany.
    Gandjour A, Ostwald DA.
    Pharmacoeconomics; 2018 Oct 15; 36(10):1285-1296. PubMed ID: 30054868
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction.
    Gaziano TA, Fonarow GC, Velazquez EJ, Morrow DA, Braunwald E, Solomon SD.
    JAMA Cardiol; 2020 Nov 01; 5(11):1236-1244. PubMed ID: 32785628
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal.
    Borges M, Afonso-Silva M, Laires PA, Gouveia M, Alarcão J, Ascenção R, Costa J.
    Expert Rev Pharmacoecon Outcomes Res; 2020 Apr 01; 20(2):199-205. PubMed ID: 31219361
    [Abstract] [Full Text] [Related]

  • 16. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
    Hubers SA, Brown NJ.
    Circulation; 2016 Mar 15; 133(11):1115-24. PubMed ID: 26976916
    [Abstract] [Full Text] [Related]

  • 17. An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.
    van der Pol S, Degener F, Postma MJ, Vemer P.
    Value Health; 2017 Mar 15; 20(3):388-396. PubMed ID: 28292483
    [Abstract] [Full Text] [Related]

  • 18. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
    Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.
    JACC Heart Fail; 2019 Jun 15; 7(6):457-465. PubMed ID: 31078482
    [Abstract] [Full Text] [Related]

  • 19. Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand.
    Krittayaphong R, Permsuwan U.
    Clin Drug Investig; 2021 Oct 15; 41(10):907-915. PubMed ID: 34533783
    [Abstract] [Full Text] [Related]

  • 20. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
    Cannon JA, Shen L, Jhund PS, Kristensen SL, Køber L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ, PARADIGM-HF Investigators and Committees.
    Eur J Heart Fail; 2017 Jan 15; 19(1):129-137. PubMed ID: 27868321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.